CN103463543B - Medical ray vulcan moxibustion - Google Patents
Medical ray vulcan moxibustion Download PDFInfo
- Publication number
- CN103463543B CN103463543B CN201310359818.8A CN201310359818A CN103463543B CN 103463543 B CN103463543 B CN 103463543B CN 201310359818 A CN201310359818 A CN 201310359818A CN 103463543 B CN103463543 B CN 103463543B
- Authority
- CN
- China
- Prior art keywords
- moxibustion
- hepatopathy
- medicine
- treatment
- diameter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 claims abstract description 28
- 208000019423 liver disease Diseases 0.000 claims abstract description 14
- 210000001835 viscera Anatomy 0.000 claims abstract description 3
- 238000000034 method Methods 0.000 claims description 7
- 239000007766 cera flava Substances 0.000 claims description 5
- 241000209094 Oryza Species 0.000 claims description 4
- 235000007164 Oryza sativa Nutrition 0.000 claims description 4
- 238000007598 dipping method Methods 0.000 claims description 4
- 235000009566 rice Nutrition 0.000 claims description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 2
- 229910052802 copper Inorganic materials 0.000 claims description 2
- 239000010949 copper Substances 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 206010003445 Ascites Diseases 0.000 abstract description 15
- 239000000126 substance Substances 0.000 abstract description 9
- 229940079593 drug Drugs 0.000 abstract description 7
- 241001619461 Poria <basidiomycete fungus> Species 0.000 abstract description 3
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 241001529821 Agastache Species 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 244000080767 Areca catechu Species 0.000 abstract 1
- 235000008658 Artemisia capillaris Nutrition 0.000 abstract 1
- 241000092668 Artemisia capillaris Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 244000236521 Bupleurum rotundifolium Species 0.000 abstract 1
- 235000015221 Bupleurum rotundifolium Nutrition 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 240000001659 Oldenlandia diffusa Species 0.000 abstract 1
- 241001162994 Rugosus Species 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract 1
- 235000013871 bee wax Nutrition 0.000 abstract 1
- 239000012166 beeswax Substances 0.000 abstract 1
- 230000003203 everyday effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 230000000694 effects Effects 0.000 description 12
- 210000004185 liver Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 206010023126 Jaundice Diseases 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 241000282414 Homo sapiens Species 0.000 description 6
- 206010030113 Oedema Diseases 0.000 description 6
- 210000001015 abdomen Anatomy 0.000 description 6
- 239000003053 toxin Substances 0.000 description 6
- 231100000765 toxin Toxicity 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 235000019504 cigarettes Nutrition 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 208000002672 hepatitis B Diseases 0.000 description 5
- 230000036407 pain Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 235000020995 raw meat Nutrition 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 235000014101 wine Nutrition 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 4
- 230000003187 abdominal effect Effects 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 102000006395 Globulins Human genes 0.000 description 3
- 108010044091 Globulins Proteins 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 206010061428 decreased appetite Diseases 0.000 description 3
- 230000002440 hepatic effect Effects 0.000 description 3
- 208000005252 hepatitis A Diseases 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 2
- 108010082126 Alanine transaminase Proteins 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000001166 anti-perspirative effect Effects 0.000 description 2
- 239000003213 antiperspirant Substances 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 210000001113 umbilicus Anatomy 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 206010019668 Hepatic fibrosis Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 206010019842 Hepatomegaly Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 206010041660 Splenomegaly Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 208000020560 abdominal swelling Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000036473 myasthenia Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medical ray vulcan moxibustion for treating hepatopathy. A drug provided by the invention comprises the following raw materials: codonopsis pilosula, white atractylodes rhizome, poria, angelica sinensis, rhizoma cyperi, fructus amomi, honeysuckle, radix paeoniae alba, radix scutellariae, fructus crataegi, herba patriniae, oldenlandia diffusa, schisandra chinensis, artemisia capillaris, Chinese thorowax root, concha ostreae, carapax amydae, agastache rugosus, areca peel, exocarpium benincasae, and beeswax. A little dough is kneaded, a small hole with the diameter of 1 cm is dug in the middle of the dough and aligns to a Shenque acupoint, an inner cylinder with the diameter of 1 cm and the height of 1.5 cm is placed on the small hole, an outer cylinder is placed on the inner cylinder, the other end of the outer cylinder is ignited, and the drug is introduced into a viscera through the Shenque acupoint. A general patient with hepatopathy undergoes the moxibustion for one time every day; an ascites patient undergoes the continuous moxibustion for three times and then undergoes the moxibustion for one time every other day at a fourth time; a yellow substance is generated by the moxibustion at a navel part, and the general patient with hepatopathy can be clinically cured after 2-3 treatment courses. The medical ray vulcan moxibustion has the effective rate of 90% and the cure rate of 70%, and has relatively good market popularizing value.
Description
Technical field
The present invention relates to a kind of medical ray vulcan moxibustion for the treatment of hepatopathy.
Background technology
Hepatopathy is generally divided into acute icteric, non-icteric type and persisting type and chronic hepatopathy.From its all kinds clinical symptoms, primary disease belongs to the category of the disease such as the traditional Chinese medical science " jaundice ", " costalgia ", " gathering ", " irritability ", " stagnation of liver-QI ", " incoordination between the liver and stomach "." Ling Shu Miraculous Pivot or Divine Axis. a five pathogenic factors section " have: " evil in liver, then pain in both sides of the chest "." Plain Questions. specimen disease passes opinion " there are again " hepatopathy dizziness, rib distention and fullness, three daily weight general pains, five days and swollen." and " Medical Treasures of the Golden Chamber " has the opinion of jaundice to control, and describes symptom and the treatment of jaundice in detail.Hepatopathy is the common disease of harm humans health, and the medicine for the treatment of hepatopathy has over one hundred kind, but therapeutic effect is not satisfactory.
Summary of the invention
Through clinical research for many years, the technical barrier that side effect is large and relapse rate is high that the medicine that the object of the invention is to solve existing treatment hepatopathy exists and provide a kind of and have no side effect, good effect, cure rate are high, be easy to carry about with one a kind of fiery thunder moxibustion of medical god for the treatment of hepatopathy easily.
Solve the problem and the technical scheme adopted: (consumption is weight portion)
The each raw material optimum amount of formula of the present invention is: (consumption is weight portion)
The preparation method of medicine of the present invention:
1. by the roguing respectively of above-mentioned Chinese medicine, drying, the process of preparing Chinese medicine, be then ground into smalls with pulverizer, cross 120 mesh sieves for subsequent use;
2. get appropriate Cera Flava and be put in igniting in copper pot, after Cera Flava fusing is over, adds smalls stirs;
3. dipping in medicine with hairbrush is applied on the rice paper of the long 30CM sheared, wide 3CM, is then rolled into long 30CM, diameter 2.8CM cylindrical outer barrel with 2 same rice paper dipping in medicine;
4. with one little dough, a diameter 1CM aperture is dug in centre, aim at SHENQUE acupoint, place diameter 1CM above, inner core that height is 1.5CM, placed by urceolus above inner core, inside and outside layer packages, light the other end of urceolus, medicine is asked for a fire power, medicine is introduced internal organs by SHENQUE acupoint, runs whole body by eight extra-channel.
Drug use method of the present invention: generally hepatopath is every a medicinal vesiculation once, moxibustion 60 minutes; Ascites person connects moxibustion 3 times, the 4th septum secundum one medicinal vesiculation once, continuous moxibustion 4 times; Once every 2 medicinal vesiculations backward, the yellow substance that the moxibustion of tripe pars muscularis goes out, damp and hot toxin is discharged, and within 3 months, is 1 course for the treatment of, the general hepatopath 2-3 clinical cure course for the treatment of; Hepatic ascites needs 3-4 the course for the treatment of, avoids acid, peppery, the irritable food such as raw meat, cigarette, wine.
Advantage of the present invention: (1) is easy to use, easy to carry; (2) evident in efficacy, more after not easily recur; (3) medicine valency is cheap.(4) novel in design.
Pharmacological action: Radix Codonopsis, invigorating the spleen and replenishing QI; The Rhizoma Atractylodis Macrocephalae, spleen reinforcing stomach reinforcing, dampness, and in.Control deficient QI of the spleen and stomach, anorexia, deficiency-distension, edema, the diseases such as jaundice; Poria, eliminating dampness and diuresis, strengthening the spleen stomach function regulating, the diseases such as mind tranquilizing and the heart calming, controls dysuria, edema distension; Radix Angelicae Sinensis, nourishing YIN of nourishing blood; Rhizoma Cyperi, resolving depression of regulating the flow of vital energy, treating the liver discomfort in the stomach, depression of QI, breast abdomen distending pain over the hypochondrium etc.; Fructus Amomi, circulation of qi promoting and in, stomach function regulating is amusing, control stomachache the spleen-distension, anorexia dyspepsia, Flos Lonicerae, heat-clearing and toxic substances removing, controls toxic swelling; The Radix Paeoniae Alba, nourishing blood to suppress the hyperactive liver, pain relieving in slow, yin fluid astringing receives antiperspirant, controls the breast abdomen pain over the hypochondriac region, spontaneous sweating, the diseases such as fever due to yin deficiency; Radix Scutellariae, lets out excess-fire, except diseases such as damp and hot, jaundice; Fructus Crataegi, helps digestion long-pending, dissipating blood stasis blood, and control meat Ji ， mass in the abdomen, phlegm retention, feeling of fullness, waits disease; Herba Patriniae, heat-clearing and toxic substances removing; Herba Hedyotidis Diffusae, clearing heat, detoxicating, dispelling dampness, the diseases such as subcutaneous ulcer of harnessing the Yellow River, this medicine can swell by diuretic; Fructus Schisandrae Chinensis, nourishing kidney of astringing the lung, receives antiperspirant arresting seminal emission, and Fructus Schisandrae Chinensis powder has the effect significantly reducing glutamate pyruvate transaminase to infectious hepatitis, and effect of gathering is fast, non-evident effect, and application type is more; Herba Artemisiae Scopariae, clearing away heat-damp and promoting diuresis, controls jaundice due to damp-heat, dysuria etc., brings down a fever rapidly after the medicinal medicine of this taste, also has positive effect to swollen the reducing of jaundice disappearance regulating liver-QI; Radix Bupleuri, reconciling superficies and interior, soothing the liver yang invigorating, fullness in the chest costalgias etc., can inducement interferon, and short antibody produces; Concha Ostreae, yin fluid astringing YANG hyperactivity suppressing, resolving phlegm and softening hard masses eliminating stagnation; Carapax Trionycis, replenishing YIN and removing heat, suppressing the hyperactive liver to relieve the wind syndrome, the diseases such as hard masses softening and resolving ， Zhi mass in the abdomen; Herba Pogostemonis, inducing diaphoresis to expel pathogens, fast gas, and in, ward off dirty, victory is wet, controls disease such as breast gastral cavity painful abdominal mass vexed grade; This two tastes medicine inducing diuresis to remove edema effect of Pericarpium Arecae, Exocarpium Benincasae; Cera Flava, plays the effect of fusing medicine.The Rhizoma Atractylodis Macrocephalae, Poria, Radix Bupleuri, Herba Hedyotidis Diffusae immunity moderation ability, prevention hepatic fibrosis, liver cirrhosis and canceration.The present invention has effect of boosting qi and nourishing yin, promoting the circulation of QI to induce diuresis detumescence, blood circulation promoting and blood stasis dispelling, hard masses softening and resolving, eliminating damp-heat, antiviral, and short HBSAg turns out cloudy, and reduce HBV-DNA, effective percentage 90%, cure rate 70%, has good promotional value.
Human body twelve channels and collaterals spreads all over abdominal part, and SHENQUE acupoint is positioned at the umbilicus position of abdominal part center, and this position is again eight extra-channel plotted point, it crisscrosses between the twelve regular channels, and communicate with all passages through which vital energy circulates, therefore have the effect regulating passages through which vital energy circulates QI and blood, thus Shenque acupuncture point on umbilicus and human diseases closely bound up.Therefore at Shenque acupuncture point moxibustion, without transdermal agent, also easily make the active ingredient in medicine intersperse among in blood through skin, run by qi-blood circulating and not by interference and the destruction of any extraneous factor, directly send to disease institute, play curative effect rapidly.
Clinical efficacy criterion and therapeutic outcome:
1, clinical data and Therapeutic Method:
1.1 select the routine hepatopath of case 200, male 120 example, women 80 example, hepatitis A 40 example, hepatitis B 150 example, hepatic ascites person 10 example, each age group of wherein falling ill all has, clinical symptoms: patient's loss of appetite, feel sick, asthenia, abdominal distention, hepatomegaly and liver function injury in various degree.
Therapeutic Method: drug use method of the present invention: general hepatopath every a medicinal vesiculation once, moxibustion 60 minutes, moxibustion 3 times, later every 2 medicinal vesiculation 1 time; Ascites person connects moxibustion 3 times, the 4th septum secundum one medicinal vesiculation once, continuous moxibustion 4 times; Once every 2 medicinal vesiculations backward, the yellow substance that the moxibustion of tripe pars muscularis goes out, damp and hot toxin is discharged, and within 3 months, is 1 course for the treatment of, the general hepatopath 2-3 clinical cure course for the treatment of; Hepatic ascites needs 3-4 the course for the treatment of, avoids acid, peppery, the irritable food such as raw meat, cigarette, wine.
1.2 curative effect judging standards: cure: after 3 courses for the treatment of of moxibustion, clinical symptoms and sign disappear, and follow up a case by regular visits to half a year without recurrence.Take a turn for the better: after 3 courses for the treatment of of moxibustion, sings and symptoms is clearly better, then after 2 courses for the treatment of of moxibustion, reach the standard of clinical cure.Invalid: after 3 courses for the treatment of of moxibustion, cardinal symptom and sign are without obvious change.Therapeutic outcome: 200 routine patients, healing person 140 example, responder 40 example, nonresponder 20 example, cure rate 70%, effective percentage 20%, total effective rate 90%.
Detailed description of the invention
Embodiment 1, the present invention are the technical scheme (consumption is weight portion) adopted that solves the problem:
Drug use method of the present invention: generally hepatopath is every a medicinal vesiculation once, moxibustion 60 minutes; Ascites person connects moxibustion 3 times, the 4th septum secundum one medicinal vesiculation once, continuous moxibustion 4 times; Once every 2 medicinal vesiculations, the yellow substance that the moxibustion of tripe pars muscularis goes out, damp and hot toxin is discharged, and avoids the irritable food such as acid, peppery, raw meat, cigarette, wine backward.
Embodiment 2, the present invention are the technical scheme (consumption is weight portion) adopted that solves the problem:
Drug use method of the present invention: generally hepatopath is every a medicinal vesiculation once, moxibustion 60 minutes; Ascites person connects moxibustion 3 times, the 4th septum secundum one medicinal vesiculation once, continuous moxibustion 4 times; Once every 2 medicinal vesiculations, the yellow substance that the moxibustion of tripe pars muscularis goes out, damp and hot toxin is discharged, and avoids the irritable food such as acid, peppery, raw meat, cigarette, wine backward.
Embodiment 3, the present invention are the technical scheme (consumption is weight portion) adopted that solves the problem:
Drug use method of the present invention: generally hepatopath is every a medicinal vesiculation once, moxibustion 60 minutes; Ascites person connects moxibustion 3 times, the 4th septum secundum one medicinal vesiculation once, continuous moxibustion 4 times; Once every 2 medicinal vesiculations, the yellow substance that the moxibustion of tripe pars muscularis goes out, damp and hot toxin is discharged, and avoids the irritable food such as acid, peppery, raw meat, cigarette, wine backward.
Case 1, Zhao, man, 40 years old, favorable to the people town, Shangqiu City Yucheng County of Henan Province Zhao Lou people from village, village same with inventor.On April 10th, 1985 goes to a doctor, and suffer from hepatitis A, hepatitis B syndrome, ascites, splenomegaly, continuous moxibustion 3 times, once a day, a kind of yellow substance appears in SHENQUE acupoint, is damp and hot toxin.By the 4th day every a medicinal vesiculation once, continuous moxibustion 4 times, later every 2 medicinal vesiculation 1 time.Treat the state of an illness after 10 days just to alleviate, continue moxibustion, to be treated to ascites not regeneration after 2 months, after treating 3 courses for the treatment of (within 3 months, being 1 course for the treatment of), check hepatitis B 5 indexs are all turned out cloudy, and follow up a case by regular visits to without recurrence after half a year.
Case 2, Lee, man, 43 years old, bridge in Grain in Ear township of Shangqiu City Yucheng County of Henan Province Hao Zhuan people from village, suffered from hepatitis B, great three positive, abdominal part, lower limbs edema, hepatosplenomegaly, without occurring ascites.On June 10th, 1996 goes to a doctor, the 1st medicinal vesiculation 1 time, connects moxibustion 2 days, later every 2 medicinal vesiculation 1 time.With moxibustion of the present invention after 1 course for the treatment of, card is got better and is turned, and face turns red cloud, and appetite increases, liver spleen touched under rib less than, abdominal part is not in edema, and lower limb are edema substantially no longer, then after 1 course for the treatment of of moxibustion, liver power checking is normal, and 5 index checkings 1,3,5 transfer feminine gender to, follows up a case by regular visits to without recurrence after half a year.
Case 3, Ma, Huang gang people from town, Dan County, Shandong Province, female, 62 years old, August 6 nineteen ninety-five went to a doctor, and suffered from hepatitis B, cirrhotic ascites.Treatment: with the present invention's moxibustion 3 times for three days on end, by the 4th day every a medicinal vesiculation once, continuous moxibustion 4 times.Later every 2 medicinal vesiculation 1 time.Treat after 15 days, abdominal swelling alleviates, and after 2 courses for the treatment of of moxibustion, health check-up ascites is a small amount of.Ascites not regeneration after moxibustion to 3 courses for the treatment of, check liver function is normal.Case 4, patient Zhao, man, 50 years old, Shangqiu City Suiyang District, Henan Province river, road village people, go to a doctor on May 6th, 2000: HBV"liang dui ban" chemical examination is great three positive, and sign shows as: upper left abdomen has a dull ache, and face is pitch-dark, fatiguability,, there is inappetence in urine color burn, feels sick and detest oily symptom.1st medicinal vesiculation 1 time, connects moxibustion 2 days, later every 2 medicinal vesiculation 1 time.After having treated 2 courses for the treatment of, HBV"liang dui ban" chemical examination is in the weak positive, and biochemical investigation: globulin 29.8g/L (normal value 20-30), sign performance is normal.
Case 5, Liu, female, Shangqiu City Xiayi County, Henan Province Hui Ting people from town, go to a doctor on June 5th, 2003, chemically examined HBV"liang dui ban" at that time: surface antigen HBSAg is positive, all the other are negative, biochemical analysis: alanine aminotransferase 990U/L (normal value 5-40), AST 820U/L (normal value 8-40), globulin 36.0g/L (normal value 20-30), total bilirubin 50Umol/L (normal value 5.1-19), conjugated bilirubin 50Umol/L (normal value 1.7-6.8).Sign shows: urine color burn, dizzy, myasthenia of limbs, vomiting.Treatment: the 1st medicinal vesiculation 1 time, connects moxibustion 2 days, later every 2 medicinal vesiculation 1 time.Chemically examine after having treated 3 courses for the treatment of: HBV"liang dui ban" is for negative, and biochemical sample: alanine aminotransferase is 25.6U/L, AST is 31.56U/L, total bilirubin 11.97Umol/L, globulin 28.91g/L, and sign is acted normally.Case 6, grandson, man, 45 years old, peasant, Shangqiu City Liangyuan District, Henan Province Liu's mouth village people, went to a doctor June 15 in 2010, right abdomen is uncomfortable, more than nausea and vomiting January, and weak 15 days, heaviness sensation over the head and body, the tired state of limbs, feeling of oppression and fullness in the chest and epigastrium, constipation with dry stool, appearance slightly contaminates Huang, and body of the tongue is light red, greasy fur.Lab testing: ALT298.3, AST126.5, remaining (-).Five indexes of hepatitis b: HBSAg is positive, and HbsAb is negative, and HbeAg is positive, and HbeAb is negative, and HbcAb is positive.Treatment: the 1st medicinal vesiculation 1 time, connects moxibustion 2 days, later every 2 medicinal vesiculation 1 time, after treat 2 courses for the treatment of, checks: ALT32.7, ASTM4.1, and the symptom such as nausea and vomiting, weak, poor appetite, uncomfortable liver area is all eliminated, again continual cure 1 the consolidate curative effect course for the treatment of.
Accompanying drawing explanation
Fig. 1 is patent figure of the present invention, and wherein 1 is dough, and 2 is inner core, and 3 is urceolus.
Claims (3)
1. treat a Medical moxibustion for hepatopathy, it is characterized in that it consists of:
2., according to a kind of Medical moxibustion for the treatment of hepatopathy according to claim 1, it is characterized in that its optimum amount is:
3., according to a kind of Medical moxibustion for the treatment of hepatopathy described in claim 1 or 2, its preparation method is:
1. by the roguing respectively of above-mentioned Chinese medicine, drying, the process of preparing Chinese medicine, be then ground into smalls with pulverizer, cross 120 mesh sieves standby
With;
2. get appropriate Cera Flava and be put in igniting in copper pot, after Cera Flava fusing is over, adds smalls stirs;
3. dipping in medicine with hairbrush is applied on the rice paper of the long 30CM sheared, wide 3CM, is then rolled into long 30CM, diameter 2.8CM cylindrical outer barrel with 2 same rice paper dipping in medicine;
4. with one little dough, a diameter 1CM aperture is dug in centre, aim at SHENQUE acupoint, place diameter 1CM above, inner core that height is 1.5CM, placed by urceolus above inner core, inside and outside layer packages, light the other end of urceolus, medicine is asked for a fire power, medicine is introduced internal organs by SHENQUE acupoint, runs whole body by eight extra-channel.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310359818.8A CN103463543B (en) | 2013-08-19 | 2013-08-19 | Medical ray vulcan moxibustion |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310359818.8A CN103463543B (en) | 2013-08-19 | 2013-08-19 | Medical ray vulcan moxibustion |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103463543A CN103463543A (en) | 2013-12-25 |
| CN103463543B true CN103463543B (en) | 2015-04-29 |
Family
ID=49788735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310359818.8A Expired - Fee Related CN103463543B (en) | 2013-08-19 | 2013-08-19 | Medical ray vulcan moxibustion |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103463543B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111420012A (en) * | 2019-11-19 | 2020-07-17 | 房纳生 | Traditional Chinese medicine composition for treating liver diseases and preparation method and application thereof |
| CN110946899A (en) * | 2020-01-09 | 2020-04-03 | 张雪琴 | Shenque moxibustion medicine tube and preparation method thereof |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1113779A (en) * | 1994-06-17 | 1995-12-27 | 殷广全 | Anti- hepatitis B preparation |
| CN1314164A (en) * | 2000-08-24 | 2001-09-26 | 张汉三 | Method for preparing liver recovery decoction for curing liver disease |
| CN1562160A (en) * | 2004-04-21 | 2005-01-12 | 金海清 | Composite medicine for treating hepatitis B complication |
| CN101168029A (en) * | 2007-11-06 | 2008-04-30 | 郭太平 | Method for manufacturing liver-smoothing, qi-regulating and detoxification capsule |
| CN102078473A (en) * | 2010-12-20 | 2011-06-01 | 陈玲 | Traditional Chinese medicine preparation for treating chronic hepatitis b and preparation method thereof |
| CN102755594A (en) * | 2012-07-19 | 2012-10-31 | 杨国兴 | Traditional Chinese medicine composition for treating acute and chronic hepatitis B and preparation method thereof |
-
2013
- 2013-08-19 CN CN201310359818.8A patent/CN103463543B/en not_active Expired - Fee Related
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1113779A (en) * | 1994-06-17 | 1995-12-27 | 殷广全 | Anti- hepatitis B preparation |
| CN1314164A (en) * | 2000-08-24 | 2001-09-26 | 张汉三 | Method for preparing liver recovery decoction for curing liver disease |
| CN1562160A (en) * | 2004-04-21 | 2005-01-12 | 金海清 | Composite medicine for treating hepatitis B complication |
| CN101168029A (en) * | 2007-11-06 | 2008-04-30 | 郭太平 | Method for manufacturing liver-smoothing, qi-regulating and detoxification capsule |
| CN102078473A (en) * | 2010-12-20 | 2011-06-01 | 陈玲 | Traditional Chinese medicine preparation for treating chronic hepatitis b and preparation method thereof |
| CN102755594A (en) * | 2012-07-19 | 2012-10-31 | 杨国兴 | Traditional Chinese medicine composition for treating acute and chronic hepatitis B and preparation method thereof |
Non-Patent Citations (5)
| Title |
|---|
| 中医药治疗慢性乙型肝炎研究集释;庄灿等;《中医药学刊》;20030430;第21卷(第4期);566-568 * |
| 中医辨治慢性病毒型肝炎概况;李川;《中医药信息》;20050731;第22卷(第4期);20-21 * |
| 巧用赵氏雷火灸配合中药治疗急危重症;黄臻等;《上海针灸杂志》;20110430;第30卷(第4期);263-264 * |
| 浅谈治疗肝病十法;董正昌等;《中医药临床杂志》;20051031;第17卷(第5期);443-444 * |
| 雷火灸研究进展;郭强中等;《现代中西医结合杂志》;20110630;第20卷(第18期);2338-2340 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103463543A (en) | 2013-12-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103550517B (en) | A kind of medicine of Hepatoma therapy | |
| CN103536748A (en) | Traditional Chinese medicament for treating goiter with depression of liver to generate pathogenic fire | |
| CN104324340B (en) | It is a kind of to treat Chinese medicine preparation of heel bone hyperosteogeny and preparation method thereof | |
| CN101085164A (en) | External-applied traditional Chinese medicine composition for treating gout | |
| CN103463543B (en) | Medical ray vulcan moxibustion | |
| CN103285206A (en) | Traditional Chinese medicinal liquor for treating rheumatic arthritis | |
| CN101700381A (en) | Pill for healing hepatitis B and softening liver | |
| CN104324350A (en) | Traditional Chinese medicine composition for chronic colitis and preparation method of traditional Chinese medicine composition | |
| CN103623247A (en) | Medicine for treating dizziness | |
| CN103239692B (en) | Chinese medicine liniment for treating skin itch and preparation method of Chinese medicine liniment | |
| CN102205067B (en) | Traditional Chinese medicine composition for treating chronic urticaria | |
| CN104547384A (en) | Oral liquid for treating paraquat poisoning and preparation method of oral liquid | |
| CN104189661A (en) | Traditional Chinese medicine for treating fibromyalgia syndrome | |
| CN104997956A (en) | Behcet's syndrome and treatment drug thereof | |
| CN104971204A (en) | Kidney-tonifying and resuscitation-inducing pill and medicinal strip cooperating with acupuncture for treating neurological tinnitus | |
| CN104740332A (en) | Traditional Chinese medicine used for treating erythema nodosum | |
| CN104922595A (en) | Traditional Chinese medicinal preparation for herpes zoster and preparation method thereof | |
| CN105998537A (en) | Traditional Chinese medicine composition for treating sudden deafness | |
| CN105663828A (en) | Medicine for treating postnatal depression and preparation method | |
| CN106310025A (en) | Traditional Chinese medicine composition for treating eczema and preparation method | |
| CN105381260A (en) | Traditional Chinese medicine for treating acquired immune deficiency syndrome and preparation method thereof | |
| CN104689291A (en) | Traditional Chinese medicine preparation for facilitating lumbar disc herniation rehabilitation and preparation method | |
| CN104888182A (en) | Traditional Chinese medicine preparation for treating postpartum abdominal pain and preparation method therefor | |
| CN105521478A (en) | Traditional Chinese medicinal composition for treating insomnia with palpitation | |
| CN103585518A (en) | Traditional Chinese medicinal preparation for treating lichen urticatus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150429 Termination date: 20150819 |
|
| EXPY | Termination of patent right or utility model |